GSK to build £400m hub in Stevenage - creating 5,000 jobs "The past 18 months has shown the UK life sciences sector at its best," a senior GSK executive said in a statement. Friday 16 July 2021 ...

GlaxoSmithKline is partnering with the UK government and the Wellcome Trust to develop a biotechnology science park located at the pharmaceutical company’s Stevenage site.

Drug and pharmaceuticals giant GSK is set to create up to 5,000 new jobs over the next ten years as part of plans to create one of Europe’s largest biotechnology campuses in Hertfordshire.

GSK's recently-unveiled plan to develop a bioscience cluster close to its main R&D site in Stevenage, UK, has moved closer to fruition, now that the first partners have joined the initiative. The ...

GlaxoSmithKline plans to build one of Europe’s largest biotechnology campuses, creating up to 5,000 UK jobs and attracting £400m of private investment. The pharmaceuticals group will sell 33 ...

Drug and pharmaceuticals giant GSK is set to create up to 5,000 new jobs over the next ten years as part of plans to create one of Europe’s largest biotechnology campuses in Hertfordshire.

Pharmaceutical giant GSK plans to create 5,000 jobs when it opens a new £400m UK hub in Stevenage, with work expected to begin in 2022. The company is planning to develop a cluster of biotech firms, ...

GSK plans to create up to 5,000 jobs in new Stevenage biotech hub Bosses will now look for a development partner in a deal they hope will unlock £400 million in new investment.

Drug and pharmaceuticals giant GSK is set to create up to 5,000 new jobs over the next ten years as part of plans to create one of Europe’s largest biotechnology campuses in Hertfordshire. Bosses said ...